Từ khóa: #IMP

Spending in Vietnam on healthcare is currently forecast to reach $23 billion next year. Photo: Le Toan

Swings and roundabouts for pharma groups so far in 2021

With risks from interruption of the medical ingredient supply chain and losses in the hospital channel, the Vietnamese pharma industry experienced a topsy-turvy first half of 2021, with potential growth set to focus on mergers and acquisitions.